PNC Financial Services Group’s Tyra Biosciences TYRA Stock Holding History

PNC Financial Services Group’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.55K	Hold	208	–	–	﹤0.01%	4545
2026 Q2	$6.64K	Sell	208 -15	-7%	-$496	﹤0.01%	4283
2026 Q1	$8.54K	Buy	223 +15	+7%	+$486	﹤0.01%	4024
2025 Q4	$5.47K	Hold	208	–	–	﹤0.01%	4200
2025 Q3	$2.91K	Buy	208 +150	+259%	+$1.71K	﹤0.01%	4399
2025 Q2	$555	Hold	58	–	–	﹤0.01%	4668
2025 Q1	$539	Hold	58	–	–	﹤0.01%	4629
2024 Q4	$806	Hold	58	–	–	﹤0.01%	4467
2024 Q3	$1.36K	Hold	58	–	–	﹤0.01%	4382
2024 Q2	$927	Hold	58	–	–	﹤0.01%	4442
2024 Q1	$951	Hold	58	–	–	﹤0.01%	4371
2023 Q4	$803	Hold	58	–	–	﹤0.01%	4348
2023 Q3	$799	Hold	58	–	–	﹤0.01%	4416
2023 Q2	$988	Hold	58	–	–	﹤0.01%	4514
2023 Q1	$932	Hold	58	–	–	﹤0.01%	4450
2022 Q4	$441	Hold	58	–	–	﹤0.01%	4545
2022 Q3	$1K	Hold	58	–	–	﹤0.01%	4352
2022 Q2	$0	Buy	+58	New	+$462	﹤0.01%	4719

Other funds holding TYRA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

PNC Financial Services Group's TYRA Position: Q3 2026 in Review

PNC Financial Services Group held its Tyra Biosciences (TYRA) position steady in Q3 2026 at 208 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #4545.

PNC Financial Services Group first reported a position in TYRA in Q2 2022 and has held it in 18 quarters since. The position peaked at $8.54K in Q1 2026. 57 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

PNC Financial Services Group held 208 shares of Tyra Biosciences worth $4.55K as of Q3 2026.
PNC Financial Services Group left its Tyra Biosciences share count unchanged in Q3 2026.
Tyra Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4545 holding.
PNC Financial Services Group first reported a position in Tyra Biosciences in Q2 2022 and has held it in 18 quarters since.
PNC Financial Services Group's Tyra Biosciences position peaked at $8.54K in Q1 2026.
57 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.